Status: Recruiting
A Non-Randomized Open Label Clinical Trial Evaluating DermaBind TL
The purpose of this clinical evaluation is to collect patient outcome data and evaluate the efficacy, safety and tolerability of HealthTech DermaBind TL™ in patients with chronic non-healing wounds in patients with chronic non-healing ulcers.
Participants needed: 150
Trial details
Phase: Phase 4Age: 18-80Biological sex: AllType: InterventionalSponsor: HealthTech Wound CareUpdated: Dec 23, 2025Locations: 10
Eligibility criteria
1. Be an adult between 18 and 80 years of age at the time of consent 2. Presence... [+6]
1. Pregnant or lactating 2. Less than 18 years of age 3. Has continued tobacco u...